Live Breaking News & Updates on Yelena Janjigian

Stay updated with breaking news from Yelena janjigian. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Debbie's Dream Foundation: Curing Stomach Cancer Supports Pioneering Gastroesophageal Cancer Research Retreat

Debbie's Dream Foundation: Curing Stomach Cancer Supports Pioneering Gastroesophageal Cancer Research Retreat
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Andrea Eidelman , Yelena Janjigian , Debbie Zelman , Rasmita Joshi , Brittnay Starks , Samuel Cytryn , Debbie Dream Foundation , Prnewswire Debbie Dream Foundation , Gastroesophageal Cancer Research Center , Memorial Sloan Kettering Cancer Center , Patient Advocacy , Case Discussion , Dream Foundation , Curing Stomach Cancer , Gastroesophageal Cancer , Executive Officer , Dream Early Career Investigator , Curing Stomach , Medical Advisory Board ,

Bispecific Checkpoint Inhibitor Improves Survival in Advanced Gastric/GEJ Cancer

Almost 50% improvement in median survival, but against a suboptimal control regimen ....

United States , Memorial Sloan Kettering Cancer Center , New York , Yelena Janjigian , Charles Bankhead , American Association For Cancer Research , Cancer Research , Medpage Today ,

First Patient Dosed With Drug Combo in Phase 2 Gastric Cancer Trial

A patient in a phase 2 trial has received the first dose of a novel combination of botensilimab and balstilimab plus agenT-979, an allogeneic cell therapy. ....

United States , Jennifer Buell , Yelena Janjigian , Gastrointestinal Oncology Service , American Cancer Society , Memorial Sloan Kettering Cancer Center , Mink Therapeutics , American Cancer , Chief Gastrointestinal Oncology Service , Vitrakvi Continues , Improve Survival , Slower Infusion , Antiemetic Drugs May Help With Nausea , Gastric Cancer , Agent 797 , Phase 2 Trial ,

First Refractory Gastric Cancer Patient Dosed in Phase 2 Trial with Novel Combination of MiNK's Allogeneic INKT Cell Therapy and Agenus' Botensilimab and Balstilimab

First Refractory Gastric Cancer Patient Dosed in Phase 2 Trial with Novel Combination of MiNK's Allogeneic INKT Cell Therapy and Agenus' Botensilimab and Balstilimab
sina.com.hk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sina.com.hk Daily Mail and Mail on Sunday newspapers.

New York , United States , Jennifer Buell , Yelena Janjigian , Mink Therapeutics Inc , Initiative To Find Treatments , Leads Investigator Sponsored Study , Memorial Sloan Kettering Cancer , Stand Up To Cancer , Find Treatments , Gastroesophageal Cancer , Whom Current Treatments Don T , First Novel Combination , Allogeneic Cell Therapy , Chief Gastrointestinal Oncology Service , Chief Executive Officer , Risk Factors ,

The Case for Biomarker Testing in Gastroesophageal Cancer

To take advantage of the latest targeted therapies in gastroesophageal cancer, physicians needed to identify patients who will benefit, but biomarker testing in this population continued to lag. ....

United States , Memorial Sloan Kettering Cancer Center , New York , San Francisco , Yelena Janjigian , American Society , Noncolorectal Gastrointestinal Cancer , Oncolorectal Gi Cancer , Biologic Therapy , Iological Marker , Ulti Biomarker Disease Activity , Multibiomarker Disease Activity , Targeted Therapy , Targeted Cancer Therapy , Alignant Neoplasia , Alignant Neoplasm , Genomics Genomic Medicine , Antineoplastic Drug , Nti Cancer Agents ,